Goldman Sachs Group Inc Xoma Corp Transaction History

Goldman Sachs Group Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 09, 2025	SELL	$19.93 - $28.12 $188,278 - $265,649	-9,447 Reduced 45.05%	11,523 $229,000
Q4 2024 Feb 11, 2025	BUY	$25.11 - $33.88 $159,348 - $215,002	6,346 Added 43.39%	20,970 $551,000
Q3 2024 Nov 14, 2024	BUY	$23.1 - $29.85 $337,814 - $436,526	14,624 New	14,624 $387,000
Q1 2023 May 14, 2024	BUY	$18.01 - $23.12 $592,583 - $760,717	32,903 New	32,903 $694,000
Q1 2023 May 11, 2023	BUY	$18.01 - $23.12 $592,583 - $760,717	32,903 New	32,903 $694,000
Q2 2022 Aug 15, 2022	SELL	$17.05 - $28.22 $473,342 - $783,443	-27,762 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$19.62 - $29.61 $1,314 - $1,983	67 Added 0.24%	27,762 $777,000
Q4 2021 Feb 14, 2022	SELL	$20.04 - $27.57 $5,010 - $6,892	-250 Reduced 0.89%	27,695 $577,000
Q3 2021 Nov 10, 2021	BUY	$23.51 - $34.79 $656,986 - $972,206	27,945 New	27,945 $692,000

6.97M

Ticker XOMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 11,450,800
Market Cap $326M
Description
XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolog...

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

Stay updated on Goldman Sachs Group Inc with notifications on news.